Update on Novel Biologic Therapies for Crohn Disease and the Impact of Imaging on Clinical Decision Making
Due to increasingly nuanced Crohn disease therapy selection and disease evaluation, radiologic assessment of transmural healing, although aspirational, may be more complete than endoscopic assessment of mucosal healing, which is the current treatment target.
Authors
- Sudha A. Anupindi (ORCID: https://orcid.org/0000-0002-7784-3108)
- Parakkal Deepak (ORCID: https://orcid.org/0000-0002-3436-9784)
- Kian Keyashian (ORCID: https://orcid.org/0000-0002-5333-2514)
- Richa Patel (ORCID: https://orcid.org/0009-0004-8780-8033)
- Bari Dane
- Matthew Nazarian
- Joel G. Fletcher (ORCID: https://orcid.org/0000-0002-8941-5434)
- Jeff L. Fidler (ORCID: https://orcid.org/0000-0001-8275-126X)
- Michael S. Gee (ORCID: https://orcid.org/0000-0002-6117-5168)
- Jonathan R. Dillman (ORCID: https://orcid.org/0000-0003-0124-0164)
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Children's Hospital of Philadelphia (US)
- Washington University in St. Louis (US)
- NYU Langone Health (US)
- Massachusetts General Hospital (US)
- Mayo Clinic in Arizona (US)
- Stanford Medicine (US)
- University of Cincinnati (US)
- University of Pennsylvania (US)
- Stanford University (US)
Publication Details
- Journal
- Radiographics
- Published
- 2026-05-28
- DOI
- https://doi.org/10.1148/rg.250162
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00